Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance

Leukemia(2024)10.1038/s41375-024-02431-3Source: DataRank Database

Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance is a research paper published in Leukemia (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: hybridTopics (35)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Antony B. Holmes ORCID,Gaia Martire ORCID,Anna Tosato,Domenico Rizzato,Federica Lovisa ORCID

Live enrichment

PubMed:39424708 PMC:PMC11717704

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: P50-CA192937

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: P30CA013696

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: CA196703-01

NCI NIH HHS

Grant: P50 CA192937

NCI NIH HHS

Grant: R01 CA196703

National Institutes of Health

Grant: 5P50CA192937-02

MSK SPORE in Lymphoma

National Institutes of Health

Grant: 3P30CA013696-21S1

CANCER CENTER CORE SUPPORT GRANT

National Institutes of Health

Grant: 5R01CA196703-09

Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Fondazione Città della Speranza

Lymphoma Research Foundation

hybridLicense: cc-by

publisherhttps://www.nature.com/articles/s41375-024-02431-3.pdf

publisherhttps://www.nature.com/articles/s41375-024-02431-3

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11717704/pdf/41375_2024_Article_2431.pdf

repositoryhttps://hdl.handle.net/11577/3556952

Unpaywallhttps://doi.org/10.1038/s41375-024-02431-3

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansBurkitt LymphomaTropomyosinPrognosisGene Expression ProfilingGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmGenetic HeterogeneityAdolescentChildChild, PreschoolFemaleMaleSingle-Cell AnalysisTranscriptomeBiomarkers, Tumor

Keywords

MaleAdolescentGene Expression ProfilingTropomyosinPrognosisBurkitt LymphomaArticleGene Expression Regulation, NeoplasticGenetic HeterogeneityDrug Resistance, NeoplasmChild, PreschoolBiomarkers, TumorHumansFemaleSingle-Cell AnalysisChildTranscriptome